# Sickle Cell Disease Cure Initiative (SCDC)

> **NIH NIH OT2** · THE EMMES COMPANY, LLC · 2020 · $4,529,314

## Abstract

No abstract provided

## Key facts

- **NIH application ID:** 10087035
- **Project number:** 3OT2HL142340-01S2
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** Robert Lindblad
- **Activity code:** OT2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $4,529,314
- **Award type:** 3
- **Project period:** 2017-09-30 → 2021-05-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10087035

## Citation

> US National Institutes of Health, RePORTER application 10087035, Sickle Cell Disease Cure Initiative (SCDC) (3OT2HL142340-01S2). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10087035. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*